Summary : Glenmark Pharmaceuticals on Monday said its subsidiary has inked a pact to commercialise AstraZeneca’s asthma drug Pulmicort Respules in the…
Tag:
Remogliflozin
-
-
Global MarketIndia
Glenmark Pharma inks exclusive licensing agreement with Lotus International
by adminby adminSummary : Under the agreement signed between Glenmark Specialty SA and the wholly-owned subsidiary of Lotus Pharmaceutical Co, Ltd (Lotus), Glenmark will…
-
Global MarketLaunch
Glenmark Pharmaceutical Launches First New Combination Drug for Type-2 Diabetes.
by adminby adminGlenmark Pharmaceuticals on Tuesday said it has launched a fixed-dose combination drug for the treatment of Type 2 diabetes in the country.…
-
IndiaTrade Marks
REMOGLIFLOZIN: INDIA IS THE FIRST COUNTRY TO GET ACCESS TO AN INNOVATIVE TYPE-2 DIABETES DRUG
by adminby adminRemogliflozin was discovered and developed by Japanese firm Kissei Pharmaceutical Co and subsequently developed by GlaxoSmithKline Plc and BHV Pharma, a…